Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Acta Gastro-Enterologica Belgica

Volumn 70, Issue 4, 2007, Pages 331-338

  Casneuf, Veerle ^a,b   Delrue, Louke ^a   Kelles, Annemarie ^a   Van Damme, Nancy ^a   Van Huysse, Jacques ^a   Berrevoet, Frederik ^a   De Vos, Martine ^a   Duyck, Philippe ^a   Peeters, Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Dept of Gastroenterology ^*  (Belgium)

Author keywords

CT; FDG PET; FDG PET CT; Lymph nodes; MDCT; Metastases; Pancreas; Pancreatitis; Staging; Tumour

Indexed keywords

DIAZEPAM; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; IODIXANOL; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG METASTASIS; MALE; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; RADIATION EXPOSURE; BONE TUMOR; COMPARATIVE STUDY; DISEASE COURSE; IMAGE PROCESSING; LABORATORY DIAGNOSIS; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADULT; AGED; BONE NEOPLASMS; DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39149104699     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. JEMAL A., MURRAY T., WARD E., SAMUELS A., TIWARI R.C., GHAFOOR A., FEUER E.J., THUN M.J. Cancer statistics, 2005. CA Cancer J. Clin., 2005, 55 : 10-30.
2. LOWENFELS A.B., MAISONNEUVE P. Epidemiology and risk factors for pancreatic cancer. Best Pract. Res. Clin. Gastroenterol., 2006, 20 : 197-209.
3. SENER S.F., FREMGEN A., MENCK H.R., WINCHESTER D.P. Pancreatic cancer, a report of treatment and survival trends for 100 313 patients diagnosed from, 1985-1995, using the National cancer database. J. Am. Coll. Surg., 1999, 189 : 1-7.
4. KATZ M.H., SAVIDES T.J., MOOSSA A.R., BOUVET M. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology, 2005, 5 : 576-590.
5. WRAY C.J., AHMAD S.A., MATTHEWS J.B., LOWY A.M. Surgery for pancreatic cancer : recent controversies and current practice. Gastroenterology, 2005, 128 : 1626-1641.
6. SOBIN L.H., WITTEKIND CH. UICC, International Union against cancer. TNM classification of malignant tumors, Sixth edition. New York : Wiley-Liss, 2002, 93-96.
7. KALRA M.K., MAHER M.M., SAHANI D.V., DIGMURTHY S., SAINI S. Current status of imaging in pancreatic diseases. J. Comput. Assist. Tomogr., 2002, 26 : 661-675.
8. SORIANO A., CASTELLS A., AYUSO C., AYUSO J.R., DE CARALT M.T., GINES M.A., REAL M.I., GILABERT R., QUINTO L., TRILLA A., FEU F., MONTANYA X., FERNANDEZ-CRUZ L., NAVARRO S. Preoperative Staging and Tumor resectability assessment of pancreatic cancer : prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging and angiography. Am. J. Gastroenterol., 2004, 99 : 492-501.
9. DIMAGNO E.P., REBER H.A., TEMPERO M.A. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology, 1999, 117 : 1464-1484.
10. FLETCHER J.G., WIERSEMA M.J., FARRELL M.A., FIDLER J.L., BURGART L.J., KOYAMA T., JOHNSON C.D., STEPHENS D.H., WARD E.M., HARMSEN W.S. Pancreatic malignancy : value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology, 2003, 229 : 81-90.
11. HARRIS J.P., NELSON R.C. Abdominal imaging with multidetector computer tomography. State of the art. J. Comput. Assist. Tomogr., 2004, 28 : S17-S19.
12. TUNACI M. Multidetector row CT of the pancreas. Eur. J. Radiol., 2004, 52 : 18-30.
13. HANBIDGE A.E. Cancer of the pancreas : the best image for early detection-CT, MRI, PET or US ? Can. J. Gastroenterol., 2002, 16 : 101-105.
14. HORTON K.M., FISHMAN E.K. Adenocarcinoma of the pancreas : CT imaging. Radiol. Clin. N. Am., 2002, 40 : 1263-1272.
15. KWON R.S., SAHANI D.V., BRUGGE W.R. Gastrointestinal cancer imaging : Deeper than the eye can see. Gastroenterology, 2005, 128 : 1538-1553.
16. JOHN T.G., GREIG J.D., CARTER D.C., GARDEN O.J. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography. Ann. Surg., 1995, 221 : 156-164.
17. CONLON K.C., DOUGHERTY E., KLIMSTRA D.S., COIT D.G., TURNBULL A.D., BRENNAN M.F. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann. Surg., 1996, 223 : 134-140.
18. YOSHIDA T., MATSUMOTO T., MORII Y., ISHIO T., KITANO S., YAMADA Y., MORI H. Staging with helical computed tomography and laparoscopy in pancreatic head cancer. Hepatogastroenterology, 2002, 49 : 1428-1431.
19. TAYLOR A.M., ROBERTS S.A., MC K MANSON J. Experience with laparoscopic ultrasonography for defining tumour resectability in carcinoma of the pancreatic head and periampullary region. Br. J. Surg., 2001, 88 : 1077-1083.
20. BARES R., KLEVER P., HAUPTMANN S., HELLWIG D., FASS J., CREMERIUS U., SCHUMPELICK V., MITTERMAYER C., BULL U. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology, 1994, 192 : 79-86.
21. KALADY M.F., CLARY B.M., GOTTFRIED M., ROHREN E.M., COLEMAN R.E., PAPPAS T.N., TYLER D.S. Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. Ann. Surg. Oncol., 2002, 9 : 799-806.
22. DIEDERICHS C.G., STAIB L., VOGEL J., GLASBRENNER B., GLATTING G., BRAMBS H.J., BEGER'H.G., RESKE S.N. Values and limitations of 18F-fluorodeoxyglucose- positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas, 2000, 20 : 109-116.
23. SAISHO H., YAMAGUCHI T. Diagnostic imaging for pancreatic cancer : computed tomography, magnetic resonance imaging and positron emission tomography. Pancreas, 2004, 28 : 273-278.
24. ROSEWICZ S., WIEDENMANN B. Pancreatic carcinoma. Lancet, 1997, 349 : 485-489.
25. BERBERAT P., FRIESS H., KASHIWAGI M., BEGER H.G., BÜCHLER M.W. Diagnosis and Staging of Pancreatic Cancer by Positron Emission Tomography. World J. Surg., 1999, 23 : 882-887.
26. SCHÖDER H., LARSON S.M., YEUNG H.W. PET/CT in oncology : integration into clinical management of lymphoma, melanoma and gastrointestinal malignancies. J. Nucl. Med., 2004, 45 Suppl 1 : 72S-81S.
27. ZIMNY M., BARES R., FASS J., ADAM G., CREMERIUS U., DOHMEN B., KLEVER P., SABRI O., SCHUMPELICK V., BUELL U. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma : a report of 106 cases. Eur. J. Nucl. Med., 1997, 24 : 678-682.
28. EARY J. Nuclear medicine in cancer diagnosis. Lancet, 1999, 354 : 853-857.
29. DELBEKE D., ROSE D.M., CHAPMAN W.C., PINSON C.W., WRIGHT J.K., BEAUCHAMP R.D., SHYR Y., LEACH S.D. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J. Nucl. Med., 1999, 40 : 1784-1791.
30. NISHIYAMA Y., YAMAMOTO Y., YOKOE K., MONDEN T., SASAKAWA Y., TSUTSUI K., SATOH K., OHKAWA M. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann. Nucl. Med., 2005, 19 : 491-497.
31. ZIMNY M., SCHUMPELICK V. Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions. Chirurg, 2001, 72 : 989-994.
32. RESKE S.N., KOTZERKE J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and, 19 September, 2000. Eur. J. Nucl. Med., 2001, 28 : 1707-1723.
33. SENDLER A., AVRIL N., HELMBERGER H., STOLLFUSS J., WEBER W., BENGEL F., SCHWAIGER M., RODER J.D., SIEWERT J.R. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose : diagnostic limitations. World J. Surg., 2000, 24 : 1121-1129.
34. KOSTAKOGLU L., HARDOFF R., MIRTCHEVA R., GOLDSMITH S.J. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics, 2004, 24 : 1411-1431.
35. BEYER T., TOWNSEND D.W., BRUN T., KINAHAN P.E., CHARRON M., RODDY R., JERIN J., YOUNG J., BYARS L., NUTT R., et al. A combined PET/CT tomograph for clinical oncology. J. Nucl. Med., 2000, 41 : 1369-1379.
36. TOWNSEND D.W., CARNEY J.P., YAP J.T., HALL N.C. PET/CT today and tomorrow. J. Nucl. Med., 2004, 45 (Suppl 1) : 4S-14S.
37. DELBEKE D., MARTIN W.H. PET and PET-CT for evaluation of colorectal carcinoma. Semin. Nucl. Med., 2004, 34 : 209-223.
38. LARDINOIS D., WEDER W., HANY T.F., KAMEL E.M., KOROM S., SEIFERT B., VON SCHULTHESS G.K., STEINERT H.C. Staging of non-small cell lung cancer with integrated positron emission tomography and computer tomography. N. Engl. J. Med., 2003, 348 : 2500-2507.
39. LOW S.Y., ENG P., KENG G.H., NG D.C. Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis. Respirology, 2006, 11 : 84-89.
40. HOEKSTRA C.J., STROOBANTS S.G., SMIT E.F., VANSTEENKISTE J., VAN TINTEREN H., POSTMUS P.E., GOLDING R.P., BIESMA B., SCHRAMEL F.J., VAN ZANDWIJK N., LAMMERTSMA A.A., HOEKSTRA O.S. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J. Clin. Oncol., 2005, 23 : 8362-8370.
41. KINKEL K., LU Y., BOTH M., WARREN R.S., THOENI R.F. Detection of Hepatic Metastases from cancers of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MR Imaging, PET) : A Meta-Analysis. Radiology, 2002, 224 : 748-756.
42. COHADE C., OSMAN M., LEAL J., WAHL R. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J. Nucl. Med., 2003, 44 : 1797-1803.
43. WEBER W.A. Use of PET for monitoring cancer therapy and for predicting outcome. J. Nucl. Med., 2005, 46 : 983-995.
44. KOSTAKOGLU L., GOLDSMITH S.J. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J. Nucl. Med., 2003, 44 : 224-239.
45. KOSTAKOGLU L., GOLDSMITH S.J. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J. Nucl. Med., 2004, 45 : 56-68.
46. TOWNSEND D.W., BEYER T., BLODGETT T.M. PET/CT scanners : a hardware approach to image fusion. Semin. Nucl. Med., 2003, 33 : 193-204.
47. DAUBE-WITHERSPOON M.E., MATEJ S., KARP J.S., LEWITT R.M. Application of the row action maximum likelihood algorithm with spherical basis functions to clinical PET imaging. Trans. Nucl. Sci., 2001, 48 : 24-30.
48. GAMBHIR S.S., CZERNIN J., SCHWIMMER J., SILVERMAN D.H., COLEMAN R.E., PHELPS M.E. A tabulated summary of the FDG PET literature. J. Nucl. Med., 2001, 42 : 1S-93S.
49. LEMKE A.J., NIEHUES SM., HOSTEN N., AMTHAUER H., BOEHMIG M., STROSZCZYNSKI C., ROHLFING T., ROSEWICZ S., FELIX R. Retrospective digital image fusion of multidetector CT and 18F-FDG PET : clinical value in pancreatic lesions - a prospective study with 104 patients. J. Nucl. Med., 2004, 45 : 1279-1286.
50. HEINRICH S., GOERRES G.W., SCHAFER M., SAGMEISTER M., BAUERFEIND P., PESTALOZZI B.C., HANY T.F., VON SCHULTHESS G.K., CLAVIEN P.A. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann. Surg., 2005, 242 : 235-243.
51. DELBEKE D., VITOLA J.V., SANDLER M.P., ARILDSEN R.C., POWERS T.A., WRIGHT J.K. Jr., CHAPMAN W.C., PINSON C.W. Staging recurrent metastatic colorectal carcinoma with PET. J. Nucl. Med., 1997, 38 : 1196-1201.
52. BERGER K.L., NICHOLSON S.A., DEHDASHTI F., SIEGEL B.A. FDG PET evaluation of mucinous neoplasms : correlation of FDG uptake with histopathological features. Am. J. Roentgenol., 2000, 174 : 1005-1008.
53. WHITEFORD M.H., WHITEFORD H.M., YEE L.F., OGUNBIYI O.A., DEHDASHTI F., SIEGEL B.A., BIRNBAUM E.H., FLESHMAN J.W., KODNER I.J., READ T.E. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis. Colon Rectum, 2000, 43 : 759-767, discussion 767-770.
54. KARMAZANOVSKY G., FEDOROV V., KUBYSHKIN V., KOTCHATKOV A. Pancreatic head cancer : accuracy of CT in determination of resectability. Abdom. Imaging, 2005, 30 : 488-500.
55. PALAZZO L., ROSEAU G., GAYET B., VILGRAIN V., BELGHITI J., FEKETE F., PAOLAGGI J.A. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy, 1993, 25 : 143-150.
56. DEWITT J., DEVEREAUX B., CHRISWELL M., MC GREEVY K., HOWARD T., IMPERIALE T.F., CIACCIA D., LANE K.A., MAGLINTE D., KOPECKY K., LEBLANC J., MC HENRY L., MADURA J., AISEN A., CRAMER H., CUMMINGS O., SCHERMAN S. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann. Intern. Med., 2004, 141 : 753-763.
57. ROCHE C.J., HUGHES M.L., GARVEY C.J., CAMPBELL F., WHITE D.A., JONES L., NEOPTOLEMOS J.P. CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. Am. J. Roentgenol., 2003, 180 : 475-480.
58. VARGAS R., NINO-MURCIA M., TRUEBLOOD W., JEFFREY R.B. Jr. MDCT in Pancreatic adenocarcinoma : prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. Am. J. Roentgenol., 2004, 182 : 419-425.
59. FROHLICH A., DIEDERICHS C.G., STAIB L., VOGEL J., BEGER H.G., RESKE S.N. Detection of liver metastases from pancreatic cancer using FDG PET. J. Nucl. Med., 1999, 40 : 250-255.
60. VALLS C., ANDIA E., SANCHEZ A., FABREGAT J., POZUELO O., QUINTERO J.C., SERRANO T., GARCIA-BOROBIA F., JORBA R. Dual-phase helical CT of pancreatic adenocarcinoma : assessment of resectability before surgery. Am. J. Roentgenol., 2002, 178 : 821-826.
61. SCHWARZ M., PAULS S., SOKIRANSKI R., BRAMBS H.J., GLASBRENNER B., ADLER G., DIEDERICHS C.G., RESKE S.N., MOLLER P., BEGER H.G. Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective ? Am. J. Surg., 2001, 182 : 243-249.
62. KONINGER J., WENTE M.N., MULLER M.W., GUTT C.N., FRIESS H., BUCHLER M.W. Surgical palliation in patients with pancreatic cancer. Langenbecks Arch. Surg., 2007, 392 : 13-21.
63. NORTON J.A., KIVLEN M., LI M., SCHNEIDER D., CHUTER T., JENSEN R.T. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch. Surg., 2003, 138 : 859-866.
64. KLEEFF J., REISER C., HINZ U., BACHMANN J., DEBUS J., JAEGER D., FRIESS H., BUCHLER M.W. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann. Surg., 2007, 245 : 566-72.